The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Newlink Genetics
Updates on phase1b/2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus checkpoint inhibitors for the treatment of unresectable stage 3 or 4 melanoma.
 
Yousef Zakharia
Consulting or Advisory Role - Castle Biosciences
Travel, Accommodations, Expenses - Newlink Genetics
 
Joseph J. Drabick
Honoraria - Merck; Novartis
Consulting or Advisory Role - Merck; Novartis; Prometheus
Research Funding - Prometheus
 
Samir Khleif
Consulting or Advisory Role - Newlink Genetics
 
Robert R. McWilliams
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
David Munn
Stock and Other Ownership Interests - Newlink Genetics
Consulting or Advisory Role - Newlink Genetics
Research Funding - Newlink Genetics
 
Charles J. Link
Employment - Newlink Genetics
 
Nicholas N. Vahanian
Employment - Newlink Genetics
 
Eugene Kennedy
No Relationships to Disclose
 
Montaser F. Shaheen
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Olivier Rixe
No Relationships to Disclose
 
Mohammed M. Milhem
Honoraria - Amgen; EMD Serono
Consulting or Advisory Role - Amgen; EMD Serono
Travel, Accommodations, Expenses - Amgen; EMD Serono